UA6576U - Method for stabilizing remission in patients with opium addiction - Google Patents
Method for stabilizing remission in patients with opium addictionInfo
- Publication number
- UA6576U UA6576U UA20041008126U UA20041008126U UA6576U UA 6576 U UA6576 U UA 6576U UA 20041008126 U UA20041008126 U UA 20041008126U UA 20041008126 U UA20041008126 U UA 20041008126U UA 6576 U UA6576 U UA 6576U
- Authority
- UA
- Ukraine
- Prior art keywords
- remission
- stabilizing
- patients
- addiction
- opium addiction
- Prior art date
Links
- 208000004224 Opium Dependence Diseases 0.000 title abstract 2
- 206010013663 drug dependence Diseases 0.000 title abstract 2
- 230000000087 stabilizing effect Effects 0.000 title abstract 2
- 230000000079 pharmacotherapeutic effect Effects 0.000 abstract 2
- ZFSXKSSWYSZPGQ-UHFFFAOYSA-N (2-hydroxycyclopentyl)azanium;chloride Chemical compound Cl.NC1CCCC1O ZFSXKSSWYSZPGQ-UHFFFAOYSA-N 0.000 abstract 1
- GDPHPXYFLPDZGH-XBTMSFKCSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)NC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 GDPHPXYFLPDZGH-XBTMSFKCSA-N 0.000 abstract 1
- 108700029992 Ala(2)-Arg(6)- enkephalin-Leu Proteins 0.000 abstract 1
- 206010012335 Dependence Diseases 0.000 abstract 1
- 102000003840 Opioid Receptors Human genes 0.000 abstract 1
- 108090000137 Opioid Receptors Proteins 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960000858 naltrexone hydrochloride Drugs 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The method for stabilizing remission in the patients with the opium addiction provides for the use of the basic pharmacotherapeutic complex in the case of the recurrence of the pathologic addiction. The pharmacotherapeutic complex comprises the blockator of the opiate receptors Naltrexone hydrochloride. The following drugs are prescribed: Naltrex per os and Dalargin intramuscularly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA20041008126U UA6576U (en) | 2004-10-07 | 2004-10-07 | Method for stabilizing remission in patients with opium addiction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA20041008126U UA6576U (en) | 2004-10-07 | 2004-10-07 | Method for stabilizing remission in patients with opium addiction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA6576U true UA6576U (en) | 2005-05-16 |
Family
ID=34883311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA20041008126U UA6576U (en) | 2004-10-07 | 2004-10-07 | Method for stabilizing remission in patients with opium addiction |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA6576U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008091177A1 (en) | 2007-01-18 | 2008-07-31 | Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' | Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
| RU2646569C2 (en) * | 2016-07-05 | 2018-03-05 | Федеральное государственное бюджетное учреждение "Новосибирский научно-исследовательский институт травматологии и ортопедии им. Я.Л. Цивьяна" Министерства здравоохранения Российской Федерации (ФГБУ "ННИИТО им. Я.Л. Цивьяна" Минздрава России) | Method for treating methadone addiction |
-
2004
- 2004-10-07 UA UA20041008126U patent/UA6576U/en unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008091177A1 (en) | 2007-01-18 | 2008-07-31 | Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' | Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes |
| RU2646569C2 (en) * | 2016-07-05 | 2018-03-05 | Федеральное государственное бюджетное учреждение "Новосибирский научно-исследовательский институт травматологии и ортопедии им. Я.Л. Цивьяна" Министерства здравоохранения Российской Федерации (ФГБУ "ННИИТО им. Я.Л. Цивьяна" Минздрава России) | Method for treating methadone addiction |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007053698A3 (en) | Methods of reducing alcohol-induced dose dumping for opioid sustained release oral dosage forms | |
| NZ590952A (en) | Use of opioid antagonists for treating urinary retention | |
| UA93543C2 (en) | Use of dosage form containing oxycodone and naloxone | |
| MY144753A (en) | Muscarinic acetylcholine receptor antagonists | |
| DE60234183D1 (en) | USE OF METHYL NALTREXONE FOR THE TREATMENT OF IMMUNOSUPPRESSION | |
| EP2076131A4 (en) | Process for preparing oxymorphone, naltrexone, and buprenorphine | |
| IL183134A0 (en) | Dosage regimen of an s1p receptor agonist | |
| UA87473C2 (en) | Muscarinic acetycholine receptor antagonists | |
| SG155880A1 (en) | Multiparticulates of preferably an opioid, and method of manufacturing using extrusion | |
| Portoghese et al. | Identity of the putative δ1-opioid receptor as a δ–κ heteromer in the mouse spinal cord | |
| WO2011020030A3 (en) | Methods and compositions to prevent addiction | |
| WO2008063301A3 (en) | Pharmaceutical compositions | |
| IL192074A0 (en) | Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same | |
| WO2009051824A3 (en) | Combination analgesic employing opioid and neutral antagonist | |
| IL179737A0 (en) | Indole derivatives as histamine receptor antagonists | |
| IL177511A (en) | Process for the synthesis of a cxcr4 antagonist | |
| ZA202201500B (en) | Opioid growth factor receptor (ogfr) antagonists, in particular naloxone and/or naltrexone for treating cancer | |
| EP2170898A4 (en) | Methods for n-demethylation of morphine and tropane alkaloids | |
| HRP20110049T1 (en) | Opioids for the treatment of the restlessness of the lower limbs | |
| TW200519108A (en) | Muscarinic acetylcholine receptor antagonists | |
| MY143499A (en) | Crf receptor antagonist and methods relating thereto | |
| WO2011154827A3 (en) | Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof | |
| CY1110152T1 (en) | USING COMBINATION OF MORPHINE AND AT LEAST ONE PHYSICAL OPIOEIDOUS ANTAGONIST IN THE TREATMENT OF ADDICTION FROM NATURAL OPIOID AND PREVENTING ABUSE MH ORAL opiate EXARTIMENOUS IN NATURAL OPIOID | |
| TW200606161A (en) | Muscarinic acetylcholine receptor antagonists | |
| TW200600500A (en) | M3 muscarinic acetylcholine receptor antagonists |